<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="122730">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01949272</url>
  </required_header>
  <id_info>
    <org_study_id>OPERA</org_study_id>
    <nct_id>NCT01949272</nct_id>
  </id_info>
  <brief_title>Optimization of PEEP for Alveolar Recruitment in ARDS</brief_title>
  <acronym>OPERA</acronym>
  <official_title>Optimization of PEEP for Alveolar Recruitment in ARDS</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hopital of Melun</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Melun Hospital Intensive Care Unit</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hopital of Melun</source>
  <oversight_info>
    <authority>France: Agence Nationale de Sécurité du Médicament et des produits de santé</authority>
    <authority>France: Committee for the Protection of Personnes</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Actual setting of PEEP in ARDS is based on tables linked to FiO2, or respiratory system
      plateau pressure (e.g EXPRESS Study) or set regarding esophageal pressure mesurement and
      transpulmonary pressure calculation. Opera study should confirm if a setting approach based
      on esophageal pressure is helpfull for any ARDS patient in ICU without deleterious
      side-effect.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2013</start_date>
  <completion_date type="Anticipated">December 2014</completion_date>
  <primary_completion_date type="Anticipated">September 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>PaO2/FiO2 ratio</measure>
    <time_frame>24 hours</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Vd/Vt ratio</measure>
    <time_frame>24 hours</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>ARDS</condition>
  <arm_group>
    <arm_group_label>ARDS</arm_group_label>
    <description>ARDS patients achieving stades II and III of Berlin 2011 Classification</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>esophageal pressure mesurement</intervention_name>
    <description>&quot;EXPRESS study&quot; ventilatory setting the optimization of PEEP with esophageal pressure mesurement</description>
    <arm_group_label>ARDS</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All ICU patients achievinf definition of ARDS stades II and III of Berlin Classification
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ARDS Stades 2 and 3 with invasive ventilation (EXPRESS settings) within 3 to 12 hours

        Exclusion Criteria:

          -  less 18 years, pregnancy, intracardiac shunt, esophageal catheter cons-indicated
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mehran Monchi, MD</last_name>
    <role>Study Director</role>
    <affiliation>Melun Hospital ICU</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>sebastien Jochmans, MD</last_name>
    <phone>33164716031</phone>
    <email>sebastien.jochmans@ch-melun.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Melun Hospital ICU</name>
      <address>
        <city>Melun</city>
        <zip>77000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sebastien Jochmans, MD</last_name>
      <phone>33164716031</phone>
      <email>sebastien.jochmans@ch-melun.fr</email>
    </contact>
    <investigator>
      <last_name>Sebastien Jochmans, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jonathan Chelly, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2013</verification_date>
  <lastchanged_date>September 19, 2013</lastchanged_date>
  <firstreceived_date>September 19, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hopital of Melun</investigator_affiliation>
    <investigator_full_name>Sebastien Jochmans, MD</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>ARDS</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Respiratory Distress Syndrome, Adult</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
